REVIEW
|
doi:10.20944/preprints202211.0177.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Real-world; Erenumab; Galcanezumab; Fremanezumab; Eptinezumab; pharmacoepidemiology; effectiveness; tolerability; safety; treatment pause; switching
Online: 9 November 2022 (11:51:21 CET)
CASE REPORT
|
doi:10.20944/preprints202301.0469.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
anti-calcitonin gene-related peptide monoclonal antibodies; cluster headache; migraine; real-world; galcanezumab; fremanezumab; comorbidity
Online: 26 January 2023 (04:24:39 CET)